Search Results - "Pérez‐Lamas, Lucía"

Hemolytic crisis due to Covid‐19 vaccination in a woman with cold agglutinin disease by Pérez‐Lamas, Lucía, Moreno‐Jiménez, Gemma, Tenorio‐Núñez, María C., Velázquez‐Kennedy, Kyra, Jiménez‐Chillón, Carlos, Astibia‐Mahillo, Beatriz, Núñez‐Torrón, Claudia, García‐Gutiérrez, Valentín, Jiménez‐Martín, Ana, Vallés‐Carboneras, Ana, López‐Jiménez, Javier F.

Get full text

Persistent Immunity against SARS-CoV-2 in Individuals with Oncohematological Diseases Who Underwent Autologous or Allogeneic Stem Cell Transplantation after Vaccination by Rodríguez-Mora, Sara, Pérez-Lamas, Lucía, Sainero, Miriam Solera, Torres, Montserrat, Sánchez-Menéndez, Clara, Corona, Magdalena, Mateos, Elena, Casado-Fernández, Guiomar, Alcamí, José, García-Pérez, Javier, Pérez-Olmeda, Mayte, Murciano-Antón, María Aranzazú, López-Jiménez, Javier, García-Gutiérrez, Valentín, Coiras, Mayte

“…The high morbimortality due to SARS-CoV-2 infection in oncohematological diseases (OHD) and hematopoietic stem cell transplant (HSCT) recipients in the…”
Get full text

Strong Cellular Immune Response, but Not Humoral, against SARS-CoV-2 in Oncohematological Patients with Autologous Stem Cell Transplantation after Natural Infection by Vigón, Lorena, Sánchez-Tornero, Adrián, Rodríguez-Mora, Sara, García-Pérez, Javier, Corona de Lapuerta, Magdalena, Pérez-Lamas, Lucía, Casado-Fernández, Guiomar, Moreno, Gemma, Torres, Montserrat, Mateos, Elena, Murciano-Antón, María Aránzazu, Alcamí, José, Pérez-Olmeda, Mayte, López-Jiménez, Javier, García-Gutiérrez, Valentín, Coiras, Mayte, On Behalf Of Multidisciplinary Group Of Study Of Covid-Mgs-Covid

“…Oncohematological patients show a low immune response against SARS-CoV-2, both to natural infection and after vaccination. Most studies are focused on the…”
Get full text

Outcomes of Chronic Myeloid Leukemia Patients after Therapeutic Failure to Asciminib, a Multicenter Observational Study by Pérez-Lamas, Lucía, Segura Diaz, Adrian, Mora, Elvira, Hidalgo Soto, Marta, Paz Coll, Antonio, De Las Heras, Natalia, Cortes, Montse, Velez Tenza, Patricia, Sierra Pacho, Magdalena, Senin, María Alicia, Angona, Anna, Cervero, Carlos, De Paz Arias, Raquel, Salamanca Cuenca, Araceli, Santaliestra, Marta, López Marin, Javier, Casado Montero, Luis Felipe, García Gutiérrez, Valentín

“…Introduction: Asciminib has recently entered the market as a promising option for patients with chronic myeloid leukemia (CML) and therapeutic failure to ³ 2…”
Get full text

Efficacy of Consolidation Therapy with Ponatinib 15mg on Treatment-Free Remission Rate in Patients with Chronic Myeloid Leukemia. Results of the Ponazero Trial by Pérez-Lamas, Lucía, Hernandez Boluda, Juan Carlos, Casado Montero, Luis Felipe, Gómez Casares, Maria Teresa, Ayala, Rosa, Xicoy, Blanca, Ferrer Marin, Francisca, Orti, Guillermo, De Paz Arias, Raquel, Osorio Prendes, Santiago, Perez Lopez, Raul, Mora, Elvira, Ruiz Nuño, Concepción, Jimenez Velasco, Antonio, Boque, Concepcion, Sierra Pacho, Magdalena, Martinez Lopez, Joaquin, Garcia Gutierrez, Valentin

“…Introduction: Discontinuation of tyrosine kinase inhibitors (TKIs) in chronic myeloid leukemia (CML) has become part of routine clinical practice in recent…”
Get full text

Toxicity of Asciminib in Real Clinical Practice; Analysis of Side Effects and Cross-Intolerance with Tyrosine Kinase Inhibitors by Pérez-Lamas, Lucía, Luna, Alejandro, Boque, Concepcion, Senin, María Alicia, Xicoy, Blanca, Giraldo, Pilar, Perez Lopez, Raul, Ruiz Nuño, Concepción, De las Heras, Natalia, Mora Casterá, Elvira, Garcia-Hernandez, Carmen, Segura Diaz, Adrian, Steegmann, Juan Luis, Velez Tenza, Patricia, Sanchez-Guijo, Fermin, Garcia-Noblejas Moya, Ana Maria, Juan Vera Goñi, Juan Antonio, Moreno Vega, Melania, Alvarez-Larran, Alberto, Cortes, Montse, Perez Encinas, Manuel, Serrano, Luis, Angona, Anna, Rosell, Ana, Lakhwani, Sunil, Colorado, Mercedes, Ramila, Elena, Cervero, Carlos, Cuevas, Beatriz, Villalon Blanco, Lucia, Hernandez Boluda, Juan Carlos, Paz Coll, Antonio, Gómez García de Soria, Valle, Fernández, Maria Jose, Casado, Luis Felipe, Alonso-Dominguez, Juan Manuel, Anguita Arance, Maria Magdalena, Carrascosa Mastell, Patricia, Salamanca Cuenca, Araceli, Jiménez-Velasco, Antonio, Ramírez, María José, López Esteban, Miguel, Sierra Pacho, Magdalena, Santaliestra, Marta, Alda Alvarez, Olga, de Paz, Raquel, García Gutiérrez, Valentín

Get full text

Asciminib in Real-Life Clinical Practice, Safety and Efficacy Profile in Chronic Myeloid Leukemia Pretreated Patients by Pérez-Lamas, Lucía, Luna, Alejandro, Boque, Concepcion, Giraldo, Pilar, Xicoy, Blanca, Casado, Luis Felipe, Sanchez-Guijo, Fermin, Ruiz Nuño, Concepción, Moreno Vega, Melania, Alvarez-Larran, Alberto, Salamanca Cuenca, Araceli, García-Noblejas, Ana, Vall-Llovera, Ferran, Perez Encinas, Manuel, Villalon, Lucia, De las Heras, Natalia, Lakhwani, Sunil, Ramila, Elena, Cuevas, Beatriz, Perez Lopez, Raul, Jiménez-Velasco, Antonio, Rosell, Ana, Escola, Angeles, Fernández, Maria Jose, Garcia-Hernandez, Carmen, Cervero, Carlos, Mora Casterá, Elvira, Sagüés, Miguel, Suarez-Varela, Sara, Vélez, Patricia, Carrascosa Mastell, Patricia, Fé Bitaube, Rocio, Serrano, Luis, Cortes, Montse, Juan Vera Goñi, Juan Antonio, Steegmann, Juan Luis, Hernandez Boluda, Juan Carlos, Gomez, Valle, Alonso-Dominguez, Juan Manuel, Araujo, Mercedes Colorado, Paz Coll, Antonio, Garcia Gutierrez, Valentín

“…Introduction: asciminib is a first-in-class STAMP (Specifically Targeting the ABL Myristoyl Pocket) inhibitor that potently inhibits aberrant kinase activity…”
Get full text

Differentiation Syndrome in a Patient With Acute Promyelocytic Leukemia: Importance of Chest CT by Gorospe Sarasúa, Luis, Ventura-Díaz, Sofía, Ayala-Carbonero, Ana María, Gambí-Pisonero, Esther, Sánchez-Tornero de la Cruz, Adrián, Pérez-Lamas, Lucía, Mirambeaux-Villanova, Rosa Mariela, Chinea-Rodríguez, Anabelle

Get full text

Hepatotoxicity as dose-limiting toxicity of the combination of bosutinib and atezolizumab in patients with chronic myeloid leukemia. Results of the ZEROLMC study by Pérez-Lamas, Lucía, de Paz Arias, Raquel, Díaz, Rosa Mª Ayala, Montero, Luis Felipe Casado, Payer, Ángel Ramírez, Sierra, Magdalena, Marín, Francisca Ferrer, López, Raúl Pérez, Cirici, Blanca Xicoy, Steegmann, Juan Luis, Gómez Casares, María Teresa, Martínez-López, Joaquín, García-Gutiérrez, Valentín

“…In the field of chronic myeloid leukemia (CML), new strategies are needed to increase the rate of successful treatment discontinuations, a crucial goal in this…”
Get full text

Outcomes of chronic myeloid leukemia patients after therapeutic failure to conventional tyrosine kinase inhibitors and asciminib by Pérez-Lamas, Lucía, Díaz, Adrián Segura, Casterá, Elvira Mora, Soto, Marta Hidalgo, Coll, Antonio Paz, De las Heras, Natalia, Cortes, Montse, Tenza, Patricia Vélez, Pacho, Magdalena Sierra, Magan, Alicia Senin, Angona, Anna, Cervero, Carlos, de Paz, Raquel, Cuenca, Araceli Salamanca, Santaliestra, Marta, Marín, Javier López, Casado, Luis Felipe, García-Gutiérrez, Valentín

“…Patients with chronic myeloid leukemia (CML) who have failed conventional tyrosine kinase inhibitors (cTKIs) and asciminib constitute a complex group of…”
Get full text

The impact of lockdown during the COVID-19 pandemic on newly acute myeloid leukemia patients: Single-centre comparative study between 2019 and 2020 cohorts in Madrid by Martín-Moro, Fernando, Núnez-Torrón, Claudia, Pérez-Lamas, Lucía, Jiménez-Chillón, Carlos, Marquet-Palomanes, Juan, López-Jiménez, Francisco Javier, Herrera-Puente, Pilar

Get full text

Síndrome de diferenciación en paciente con leucemia promielocítica aguda: importancia de la TC de tórax by Gorospe Sarasúa, Luis, Ventura-Díaz, Sofía, Ayala-Carbonero, Ana María, Gambí-Pisonero, Esther, Sánchez-Tornero de la Cruz, Adrián, Pérez-Lamas, Lucía, Mirambeaux-Villanova, Rosa Mariela, Chinea-Rodríguez, Anabelle

Get full text

Differentiation Syndrome in a Patient With Acute Promyelocytic Leukemia: Importance of Chest CT by Gorospe Sarasúa, Luis, Ventura-Díaz, Sofía, Ayala-Carbonero, Ana María, Gambí-Pisonero, Esther, Sánchez-Tornero de la Cruz, Adrián, Pérez-Lamas, Lucía, Mirambeaux-Villanova, Rosa Mariela, Chinea-Rodríguez, Anabelle

Get full text

Toxicity of Asciminib in Real Clinical Practice: Analysis of Side Effects and Cross-Toxicity with Tyrosine Kinase Inhibitors by Pérez-Lamas, Lucía, Luna, Alejandro, Boque, Concepción, Xicoy, Blanca, Giraldo, Pilar, Pérez López, Raúl, Ruiz Nuño, Concepción, De Las Heras, Natalia, Mora Casterá, Elvira, López Marín, Javier, Segura Díaz, Adrián, Gómez, Valle, Vélez Tenza, Patricia, Sierra Pacho, Magdalena, Vera Goñi, Juan Antonio, Moreno Vega, Melania, Alvarez-Larrán, Alberto, Cortés, Montse, Pérez Encinas, Manuel, Carrascosa Mastell, Patricia, Angona, Anna, Rosell, Ana, Lakhwani, Sunil, Colorado, Mercedes, Ramila, Elena, Cervero, Carlos, Cuevas, Beatriz, Villalón Blanco, Lucía, de Paz, Raquel, Paz Coll, Antonio, Fernández, María José, Felipe Casado, Luis, Alonso-Domínguez, Juan Manuel, Anguita Arance, María Magdalena, Salamanca Cuenca, Araceli, Jiménez-Velasco, Antonio, Prendes, Santiago Osorio, Santaliestra, Marta, Lis Chulvi, María José, Hernández-Boluda, Juan Carlos, García-Gutiérrez, Valentín

“…(1) Background: Despite the prognostic improvements achieved with tyrosine kinase inhibitors (TKIs) in chronic myeloid leukemia (CML), a minority of patients…”
Get full text